Vitiligo and cutaneous malignancy: what is the risk?
Vitiligo is a disorder of depigmentation affecting up to two percent of the global population. It is a long-held belief that patients with vitiligo have an increased risk for skin cancers due to the loss of melanin, a pigment which protects the skin against carcinogenesis. Phototherapy, a mainstay t...
Saved in:
Main Authors: | Sahngeun Jenny Mun, Monisha Gupta |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-12-01
|
Series: | Pigment International |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/pigmentinternational_28_24 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phototherapy in vitiligo
by: Anuradha Bishnoi, et al.
Published: (2024-12-01) -
A case of spindle cell squamous cell carcinoma of the tongue complicated by verrucous carcinoma
by: Yusuke Matsuzaki, et al.
Published: (2025-03-01) -
Advances in the etiopathogenesis of vitiligo
by: Thomas Mathew, et al.
Published: (2024-12-01) -
Histological risk score and its role in predicting recurrence in early-stage oral squamous cell carcinomas
by: Daphne Fonseca, et al.
Published: (2023-07-01) -
Hedgehog pathway inhibitors (HHI) combined with radiotherapy and immunotherapy for advanced basal cell carcinoma: a case report
by: Zhuren Ruan, et al.
Published: (2025-12-01)